chevron_leftBack
As of 7 June 2026, Boule Diagnostics AB (publ) has a market cap of $15.83M USD, ranking #38648 globally and #587 in Sweden.
It ranks #3447 in the Healthcare sector, and #734 in the Medical Devices industry.
Key Stats
Market Cap
$15.83MUSD
148.34M SEK
Enterprise Value
$37.14MUSD
351.84M SEK
Revenue (TTM)
$51.04MUSD
478.39M SEK
EBITDA (TTM)
$5.01MUSD
47.49M SEK
Net Income (TTM)
-$859.17KUSD
-8.05M SEK
EBITDA Margin
9.9%
Profit Margin
-1.7%
Forward PE
4.5
PS Ratio
0.3
PB Ratio
0.9
EV/EBITDA
7.4
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Torben Nielsen
open_in_new
Employees
200
Founded
1956
Website
boule.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -5.5% | -8.9% | -8.9% | -28% | -38% | -57% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
BOUL
Boule Diagnostics AB
ISIN: SE0011231158
Shares Out.:
Shares Outstanding:
38.833M1
Shares Float:
28.845M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
3.61 SEK |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Boule Diagnostics AB (publ)
Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and the Middle East. The company provides hematology analyzers, reagents, controls, and calibrators, under the Swelab, and Medonic brands; and veterinary hematology and clinical chemistry analyzer systems, as well as reagents and panels under the Exigo brand. It serves small and medium-sized hospitals, clinics, laboratories, and veterinary clinics, and other diagnostics firms. The company was founded in 1956 and is headquartered in Spånga, Sweden.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
STO: GETI-B
|
$5.59B
35K%
52.4B SEK
|
22.2
|
|
|
S
STO: SCIB
|
$4.85B
31K%
45.5B SEK
|
-
|
|
STO: EKTA-B
|
$2.23B
14K%
20.86B SEK
|
-
|
|
STO: VITR
|
$1.59B
10K%
14.87B SEK
|
-
|
|
STO: BONEX
|
$1.53B
10K%
14.32B SEK
|
78.5
|
|
STO: XVIVO
|
$907.38M
6K%
8.5B SEK
|
115.1
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: TMO
|
$173.27B
1M%
|
25.8
|
|
NASDAQ: ISRG
|
$160.73B
1M%
|
56.7
|
|
NYSE: ABT
|
$159.07B
1M%
|
25.6
|
|
NYSE: DHR
|
$126.55B
800K%
|
34.7
|
|
NYSE: SYK
|
$120.69B
762K%
|
38.3
|
|
NYSE: MDT
|
$101.9B
644K%
|
22.2
|
chevron_leftBack